A randomized non-inferiority study of low-dose and standard-dose ticagrelor after intervention for acute coronary syndrome: study protocol for the TIGER STUDY

BACKGROUND: Current guidelines recommend that patients with acute coronary syndrome (ACS) who have successfully undergone percutaneous coronary intervention (PCI) should continue to use dual antiplatelet therapy (DAPT) for 12 months. The long-term use of standard-dose dual antiplatelet therapy will...

Descripción completa

Detalles Bibliográficos
Autores principales: Pang, Yanan, Ma, Minglu, Xia, Jiachun, Wang, Dong, YanChen, Ye, Jianfei, Jia, Zhongwei, Wu, Sicheng, Yang, Jian, Hou, Lei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8898426/
https://www.ncbi.nlm.nih.gov/pubmed/35248132
http://dx.doi.org/10.1186/s13063-022-06124-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8898426/
https://www.ncbi.nlm.nih.gov/pubmed/35248132
http://dx.doi.org/10.1186/s13063-022-06124-z

Ejemplares similares